Vimarsana
Biggest News Aggregation in the World

Sam Riccitelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sam Riccitelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sam Riccitelli Today - Breaking & Trending Today

Biocept Inc sees poster at ASCO spotlight impressive performance of its CNSide assay compared to cytology in detecting a type of cancer - Vimarsana News

Biocept Inc sees poster at ASCO spotlight impressive performance of its CNSide assay compared to cytology in detecting a type of cancer

Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of...

Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept's CNSide™ Versus Cytology - Vimarsana News

Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept's CNSide™ Versus Cytology

Real-world retrospective study showed increased sensitivity for CNSide relative to standard cerebral spinal fluid cytology in detecting leptomeningeal metastases ... | June 5, 2023

Enrollment Begins in FORESEE Clinical Trial Using Biocept's CNSide™ to Evaluate Patients with Leptomeningeal Metastases - Vimarsana News

Enrollment Begins in FORESEE Clinical Trial Using Biocept's CNSide™ to Evaluate Patients with Leptomeningeal Metastases

Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary... | March 24, 2023

Biocept, Inc. (NASDAQ:BIOC) Q3 2022 Earnings Call Transcript - Vimarsana News

Biocept, Inc. (NASDAQ:BIOC) Q3 2022 Earnings Call Transcript

Operator: Good day, and welcome to the Biocept Third Quarter Financial Results Conference Call. All participants are in a listen-only mode.

Biocept to Host Key Opinion Leader Webinar on October 14 to Discuss its Proprietary CNSide™ Assay to Detect and Quantify Cancer that Metastasized to the Central Nervous System - Vimarsana News

Biocept to Host Key Opinion Leader Webinar on October 14 to Discuss its Proprietary CNSide™ Assay to Detect and Quantify Cancer that Metastasized to the Central Nervous System

Presenters include leading neuro-oncologists Dr. Priya U. Kumthekar of Northwestern University and Dr. Seema A. Nagpal of Stanford University ... | October 6, 2022